90 -11 (49) 2022 -Vasilevsky E.A., Aleinik V.A. — PLACE OF POLYMORPHISM OF MMP AND VEGFA GENES IN THE DEVELOPMENT OF CHRONIC VENOUS INSUFFICIENCY OF THE VEINS OF THE LOWER EXTREMITIES

PLACE OF POLYMORPHISM OF MMP AND VEGFA GENES IN THE DEVELOPMENT OF CHRONIC VENOUS INSUFFICIENCY OF THE VEINS OF THE LOWER EXTREMITIES

Vasilevsky E.A., Andijan State Medical Institute

Aleinik V.A., Andijan State Medical Institute

Musashaikhov Kh.T., Andijan State Medical Institute

Dadabaev O.T. Andijan State Medical Institute

Resume

Chronic venous insufficiency (CVI) is an important medical problem in developed countries. It was important to determine one of the leading roles in the pathogenesis of CVI, the interaction of matrix metalloproteinases (MMPs) as important mediators of the degenerative process and vascular endothelial growth factor (VEGFA). The study included 98 patients aged 20 to 78 years with chronic venous insufficiency, including, in accordance with the CEAP classification, 45 patients with moderate CVI (class C3-C4) and 53 patients with severe CVI (class C5-C6). The results obtained in the course of the study reliably indicate the presence of an association between the carriage of the Arg allele and the Gln/Arg and Arg/Arg genotypes of the Gln279Arg polymorphism in the MMP9 gene, as well as the carriage of the T allele and the C/T and T/T genotypes of the C936T polymorphism in the VEGFA gene with the risk of developing complicated forms of CVI.

Keywords: chronic venous insufficiency, matrix metalloproteinases, vascular endothelial growth factor, polymorphism, MMP-9, VEGFA

First page

514

Last page

519

For citation: Vasilevsky E.A., Aleinik V.A., Musashaikhov Kh.T., Dadabaev O.T. PLACE OF POLYMORPHISM OF MMP AND VEGFA GENES IN THE DEVELOPMENT OF CHRONIC VENOUS INSUFFICIENCY OF THE VEINS OF THE LOWER EXTREMITIES //New Day in Medicine 11(49)2022 514-519 https://clck.ru/32sfN8

LIST OF REFERENCES:

1. Barallobre-Barreiro J., Oklu R., Lynch M. et al (2016) Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins. //Cardiovasc Res 110:419–430.
2. Benjamin M.M., Khalil R.A. (2012) Matrix metalloproteinase inhib-itors as investigative tools in the pathogenesis and management of vascular disease. //EXS 103:209–279
3. Castro-Ferreira R., Cardoso R., Leite-Moreira A., Mansilha A. (2018) The role of endothelial dysfunction and inflammation in chronic venous disease. //Ann Vasc Surg 46:380–393
4. Eelen G., de Zeeuw P., Simons M., Carmeliet P. (2015) Endothelial cell metabolism in normal and diseased vasculature. //Circ Res 116: 1231–1244
5. Eklöf B., Rutherford R.B., Bergan J.J. et al (2004) American Venous Forum International Ad Hoc Committee for Revision of the CEAP classification. Revision of the CEAP classification for chronic ve-nous disorders: consensus statement. //J Vasc Surg 40:1248–1252
6. Flórez A., De Haro J., Bleda S. et al (2013) Analysis of vascular endothelial growth factor gene expression in the tissues of patients with chronic venous insufficiency. //Phlebology 28:32–37
7. Humphrey J.D., Milewicz D.M. (2017) Aging, smooth muscle vitality, and aortic integrity. //Circ Res 120:1849–1851
8. Koczy-Baron E., Kasperska-Zając A. (2014) The role of vascular endothelial growth factor in inflammatory processes. //Postepy Hig Med Dosw 68:57–65
9. Kowalewski R., Małkowski A., Sobolewski K. et al (2011) Vascular endothelial growth factor and its receptor in the varicose vein wall. //Act Angiol 17:141–149
10. Lim C.S., Qiao X., Reslan O. et al (2011) Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. //J Vasc Surg 53:764–773
11. Lo Presti R., Hopps E., Caimi G. (2017) Gelatinases and physical exercise: a systematic review of evidence from human studies. //Medicine (Baltimore) 96:e8072
12. MacColl E., Khalil R.A. (2015) Matrix Metalloproteinases as regula-tors of vein structure and function: implications in chronic venous disease. //J Pharmacol Exp Ther 355:410–428
13. Park H.J., Kim M.K., Kim Y. et al (2017) Gastrin-releasing peptide promotes the migration of vascular smooth muscle cells through upregulation of matrix metalloproteinase-2 and -9. //BMB Rep 50: 628–633
14. Rafetto J.D., Khalil R.A. (2008) Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. //Biochem Pharmacol 75:346–359
15. Rafetto J.D., Qiao X., Koledova V.V. et al (2008) Prolonged increases in vein wall tension increase matrix metalloproteinases and de-crease constriction in rat vena cava: potential implications in vari-cose veins. //J Vasc Surg 48:447–456
16. Raffetto J.D., Khalil R.A. (2008) Mechanisms of varicose vein for-mation: valve dysfunction and wall dilation. //Phlebology 23:85–98
17. Xu J., Shi G.P. (2014) Vascular wall extracellular matrix proteins and vascular diseases. //Biochim Biophys Acta 1842:2106–2119